Acute chest pain (ACP) is a common yet challenging presentation in emergency departments. Its differential diagnosis is broad, ranging from benign conditions to life-threatening diseases.
Effective management of ACP requires a systematic approach. A thorough history, physical examination, and appropriate investigations are crucial. Attention should be given to associated symptoms such as shortness of breath, nausea, and sweating, which may indicate myocardial ischemia.
Electrocardiogram and cardiac biomarkers are essential for early detection of acute coronary syndromes. Additional diagnostic tools, such as chest radiography or computed tomography, may be required to identify non-cardiac causes.
Risk stratification tools, such as the HEART score, can aid in clinical decision-making. Patients with low-risk scores may be suitable for outpatient management, while those with high-risk scores require hospital admission.
In conclusion, a comprehensive approach to ACP is essential for accurate diagnosis and effective management. By integrating clinical findings with appropriate investigations and risk stratification tools, healthcare professionals can ensure optimal patient outcomes.
1.
Q&A: Nipple-Sparing Mastectomy After Breast Radiation
2.
healthy despite having advanced cancer.
3.
Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.
4.
PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging
5.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
1.
Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer
2.
An Overview Of Daunorubicin: What Is It Used For And How Does It Work?
3.
A New Hope: Exploring the Benefits of Exenteration for Cancer Patients
4.
Blood Donation Sustainability Through Behavioral Science
5.
Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation